Oral administration of the NAALADase inhibitor GPI-5693 attenuates cocaine-induced reinstatement of drug-seeking behavior in rats.

[1]  Z. Xi,et al.  N-acetylaspartylglutamate (NAAG) inhibits intravenous cocaine self-administration and cocaine-enhanced brain-stimulation reward in rats , 2010, Neuropharmacology.

[2]  D. Hampson,et al.  The Neuroactive Peptide N-Acetylaspartylglutamate Is Not an Agonist at the Metabotropic Glutamate Receptor Subtype 3 of Metabotropic Glutamate Receptor , 2009, Journal of Pharmacology and Experimental Therapeutics.

[3]  J. Kew,et al.  Effects of N-acetylaspartylglutamate (NAAG) at group II mGluRs and NMDAR , 2009, Neuropharmacology.

[4]  P. Kalivas,et al.  Glutamate and reinstatement. , 2009, Current opinion in pharmacology.

[5]  J. Stewart.  Psychological and neural mechanisms of relapse , 2008, Philosophical Transactions of the Royal Society B: Biological Sciences.

[6]  G. Imre.  The preclinical properties of a novel group II metabotropic glutamate receptor agonist LY379268. , 2007, CNS drug reviews.

[7]  T. Tsukamoto,et al.  Progress in the discovery and development of glutamate carboxypeptidase II inhibitors. , 2007, Drug discovery today.

[8]  W. Spooren,et al.  Allosteric Modulators for mGlu Receptors , 2007, Current neuropharmacology.

[9]  Y. Shaham,et al.  Systemic and Central Amygdala Injections of the mGluR2/3 Agonist LY379268 Attenuate the Expression of Incubation of Cocaine Craving , 2007, Biological Psychiatry.

[10]  W. Danysz,et al.  Effects of NAAG peptidase inhibitor 2-PMPA in model chronic pain – relation to brain concentration , 2006, Neuropharmacology.

[11]  Z. Xi,et al.  Cannabinoid CB1 Receptor Antagonist AM251 Inhibits Cocaine-Primed Relapse in Rats: Role of Glutamate in the Nucleus Accumbens , 2006, The Journal of Neuroscience.

[12]  R. Spealman,et al.  Pharmacological Stimulation of Group II Metabotropic Glutamate Receptors Reduces Cocaine Self-Administration and Cocaine-Induced Reinstatement of Drug Seeking in Squirrel Monkeys , 2006, Journal of Pharmacology and Experimental Therapeutics.

[13]  L. Gitajn,et al.  The Novel Dopamine D3 Receptor Antagonist NGB 2904 Inhibits Cocaine's Rewarding Effects and Cocaine-Induced Reinstatement of Drug-Seeking Behavior in Rats , 2006, Neuropsychopharmacology.

[14]  J. Neale,et al.  NAAG peptidase inhibitor increases dialysate NAAG and reduces glutamate, aspartate and GABA levels in the dorsal hippocampus following fluid percussion injury in the rat , 2006, Journal of neurochemistry.

[15]  J. Peters,et al.  The group II metabotropic glutamate receptor agonist, LY379268, inhibits both cocaine- and food-seeking behavior in rats , 2006, Psychopharmacology.

[16]  Qun Liu,et al.  Structural optimization of thiol-based inhibitors of glutamate carboxypeptidase II by modification of the P1' side chain. , 2006, Journal of medicinal chemistry.

[17]  M. Baslow.  NAAG peptidase as a therapeutic target: Potential for regulating the link between glucose metabolism and cognition. , 2006, Drug news & perspectives.

[18]  J. Neale,et al.  The neurotransmitter N-acetylaspartylglutamate in models of pain, ALS, diabetic neuropathy, CNS injury and schizophrenia. , 2005, Trends in pharmacological sciences.

[19]  D. Hilt,et al.  The central nervous system effects, pharmacokinetics and safety of the NAALADase-inhibitor GPI 5693. , 2005, British journal of clinical pharmacology.

[20]  S. M. Anderson,et al.  Cocaine-induced alterations in dopamine receptor signaling: implications for reinforcement and reinstatement. , 2005, Pharmacology & therapeutics.

[21]  T. Tsukamoto,et al.  Enantiospecificity of glutamate carboxypeptidase II inhibition. , 2005, Journal of medicinal chemistry.

[22]  F. Weiss,et al.  Preferential Effects of the Metabotropic Glutamate 2/3 Receptor Agonist LY379268 on Conditioned Reinstatement versus Primary Reinforcement: Comparison between Cocaine and a Potent Conventional Reinforcer , 2004, The Journal of Neuroscience.

[23]  P. Kalivas,et al.  Glutamate systems in cocaine addiction. , 2004, Current opinion in pharmacology.

[24]  A. Keller,et al.  GCP II (NAALADase) inhibition suppresses mossy fiber-CA3 synaptic neurotransmission by a presynaptic mechanism. , 2004, Journal of neurophysiology.

[25]  Qun Liu,et al.  Synthesis and biological evaluation of thiol-based inhibitors of glutamate carboxypeptidase II: discovery of an orally active GCP II inhibitor. , 2003, Journal of medicinal chemistry.

[26]  P. Kalivas,et al.  Modulation of Group II Metabotropic Glutamate Receptor Signaling by Chronic Cocaine , 2002, Journal of Pharmacology and Experimental Therapeutics.

[27]  Y. Shaham,et al.  Neurobiology of Relapse to Heroin and Cocaine Seeking: A Review , 2002, Pharmacological Reviews.

[28]  Zheng-Xiong Xi,et al.  Group II metabotropic glutamate receptors modulate extracellular glutamate in the nucleus accumbens. , 2002, The Journal of pharmacology and experimental therapeutics.

[29]  B. Slusher,et al.  Expression and acquisition of the conditioned place preference response to cocaine in rats is blocked by selective inhibitors of the enzyme N‐acetylated‐α‐linked‐acidic dipeptidase (NAALADASE) , 2001, Synapse.

[30]  W. Rea,et al.  Modulation of behavioral sensitization to cocaine by NAALADase inhibition , 2000, Synapse.

[31]  F. Tortella,et al.  Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury , 1999, Nature Medicine.

[32]  P. Kalivas,et al.  The regulation of dopamine transmission by metabotropic glutamate receptors. , 1999, The Journal of pharmacology and experimental therapeutics.

[33]  F. Monsma,et al.  Characterization of [3H]‐(2S,2′R,3′R)‐2‐(2′,3′‐dicarboxy‐ cyclopropyl)glycine ([3H]‐DCG IV) binding to metabotropic mGlu2 receptor‐transfected cell membranes , 1998, British journal of pharmacology.

[34]  J. Neale,et al.  N‐Acetylaspartylglutamate Selectively Activates mGluR3 Receptors in Transfected Cells , 1997, Journal of neurochemistry.